KHN Morning Briefing

Summaries of health policy coverage from major news organizations

Poorer Cancer Patients Less Likely To Have Access To Experimental Drug Trials

Reuters: Fewer Poor Cancer Patients Referred For Drug Trials
Among people with advanced cancer, poorer patients are less likely to be referred for clinical trials of experimental drugs, a new study from the UK suggests. Because those early trials will eventually help regulators decide if drugs should be approved for a wider population, it's important that test patients be representative of people the medications are designed to treat, researchers said (Pittman, 12/4).

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.